Abstract GS3-06: Biomarker evaluation in the phase 3 ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer. San Antonio Breast Cancer Symposium 2020 - Hurvitz, S A; Tolaney, S M; Punie, K (Cancer Res, 2021)
et al.